スイスでは,より高い標高で冠動脈疾患と脳卒中による死亡率が低くなります
David Faeh1, Felix Gutzwiller, Matthias Bopp
1University of Zurich, Institute of Social and Preventive Medicine, Hirschengraben 84, 8001 Zürich, Switzerland.
Circulation
|July 29, 2009
まとめ
高地での生活は,冠動脈疾患と脳卒中による死亡率の低下と関連しています. 高 altitude で生まれたことは,追加の保護を提供しており,気候要因が役割を果たす可能性があることを示唆しています.
科学分野:
- 環境衛生 環境衛生 環境衛生
- 心血管伝染病学 心血管伝染病学
- 地理医学 地理医学
背景:
- 標高と心血管疾患に関する以前の研究は,人口の異質性と生態学的設計のために矛盾する結果をもたらしました.
- 心血管疾患による死亡率に対する出生地の高さの影響は十分に検討されていない.
- この研究では,住宅地と出生地の高さとの関係で冠動脈疾患と脳卒中死亡率を調査しています.
研究 の 目的:
- 住宅の高さと冠動脈疾患と脳卒中の死亡率との関連性を評価する.
- 心血管疾患による死亡率に対する出生地の高さの影響を決定する.
- 潜在的混乱要因と,気候などの根本的なメカニズムを探求する.
主な方法:
- スイス・ナショナル・コホート (Swiss National Cohort) のデータを活用し,縦断的な国勢調査に基づく研究を行いました.
- 259mから1960mまでの高さに住む164万人 (40-84歳) の死亡率データ (1990-2000年) を分析した.
- 相対リスクの計算に多変数ポアソン回帰を用いて,社会人口統計情報と出生地で調整した.
主要な成果:
- 冠動脈疾患による死亡率は,高度が1000m上昇するごとに22%減少した.
- 脳卒中による死亡率は,高度が1000m上昇するごとに12%減少した.
- 居住地よりも高いまたは低い高さで生まれた個人は,死亡リスクが変化したことを示しました.
結論:
- 高地での生活は,冠動脈疾患と脳卒中の死亡率に対する一貫した保護効果を示しており,これは混同因子とは無関係です.
- 高地での出産は,冠動脈疾患の死亡率に対する追加の独立した利点を提供します.
- 観察された保護効果は,従来の心血管疾患の危険因子に起因する可能性は低いため,気候の影響が有意である可能性を示唆しています.
関連する概念動画
Factors Affecting Respiration
8.8K
Respiration is a crucial physiological function involving exchanging oxygen (O2) and carbon dioxide (CO2) between an organism and its environment. Various factors can impact this essential process:
8.8K
Exercise and Cardiac Output
3.8K
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
3.8K
Exercise and Cardiovascular Response
6.7K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.7K
Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Hypertension IV: Drug Therapy and Lifestyle Modifications
1.0K
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
1.0K
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741


